nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—ADRA1D—Adrenoceptors—ADRB1—periodontitis	0.112	0.112	CbGpPWpGaD
Methoxamine—ADRA1B—Adrenoceptors—ADRB1—periodontitis	0.093	0.093	CbGpPWpGaD
Methoxamine—ADRA1A—Adrenoceptors—ADRB1—periodontitis	0.0826	0.0826	CbGpPWpGaD
Methoxamine—ADRA1D—Monoamine GPCRs—ADRB1—periodontitis	0.0396	0.0396	CbGpPWpGaD
Methoxamine—ADRA1D—Amine ligand-binding receptors—ADRB1—periodontitis	0.0333	0.0333	CbGpPWpGaD
Methoxamine—ADRA1B—Monoamine GPCRs—ADRB1—periodontitis	0.0329	0.0329	CbGpPWpGaD
Methoxamine—ADRA1A—Monoamine GPCRs—ADRB1—periodontitis	0.0292	0.0292	CbGpPWpGaD
Methoxamine—ADRA1A—Endothelin Pathways—ADRB1—periodontitis	0.0292	0.0292	CbGpPWpGaD
Methoxamine—ADRA1B—Amine ligand-binding receptors—ADRB1—periodontitis	0.0276	0.0276	CbGpPWpGaD
Methoxamine—ADRA1A—Amine ligand-binding receptors—ADRB1—periodontitis	0.0246	0.0246	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Other—CXCR2—periodontitis	0.0227	0.0227	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0131	0.0131	CbGpPWpGaD
Methoxamine—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.0119	0.0119	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0109	0.0109	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—CXCL3—periodontitis	0.01	0.01	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00988	0.00988	CbGpPWpGaD
Methoxamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00985	0.00985	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00968	0.00968	CbGpPWpGaD
Methoxamine—ADRA1B—LPA receptor mediated events—MMP2—periodontitis	0.00912	0.00912	CbGpPWpGaD
Methoxamine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00875	0.00875	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00846	0.00846	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CXCL3—periodontitis	0.0083	0.0083	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.0082	0.0082	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00768	0.00768	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00765	0.00765	CbGpPWpGaD
Methoxamine—ADRA1B—LPA receptor mediated events—CXCL8—periodontitis	0.00757	0.00757	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CXCL3—periodontitis	0.00737	0.00737	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00728	0.00728	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00702	0.00702	CbGpPWpGaD
Methoxamine—ADRA1B—LPA receptor mediated events—MMP9—periodontitis	0.00685	0.00685	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00673	0.00673	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00658	0.00658	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00655	0.00655	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—CXCR2—periodontitis	0.00644	0.00644	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00637	0.00637	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00635	0.00635	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00624	0.00624	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00566	0.00566	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CXCL3—periodontitis	0.00565	0.00565	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00564	0.00564	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00559	0.00559	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00546	0.00546	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00544	0.00544	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CXCR2—periodontitis	0.00535	0.00535	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CXCL3—periodontitis	0.00513	0.00513	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—CCR2—periodontitis	0.00501	0.00501	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—ADRB1—periodontitis	0.00499	0.00499	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00496	0.00496	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00485	0.00485	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00483	0.00483	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CXCR2—periodontitis	0.00475	0.00475	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CXCL3—periodontitis	0.00469	0.00469	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CXCL3—periodontitis	0.00426	0.00426	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CXCL3—periodontitis	0.00417	0.00417	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CCR2—periodontitis	0.00416	0.00416	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—ADRB1—periodontitis	0.00414	0.00414	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—VIP—periodontitis	0.00409	0.00409	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CXCL3—periodontitis	0.00378	0.00378	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—VIP—periodontitis	0.00371	0.00371	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CCR2—periodontitis	0.00369	0.00369	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—ADRB1—periodontitis	0.00368	0.00368	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CXCR2—periodontitis	0.00364	0.00364	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—VIP—periodontitis	0.00339	0.00339	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CXCR2—periodontitis	0.00331	0.00331	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00324	0.00324	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—VIP—periodontitis	0.00308	0.00308	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CXCL3—periodontitis	0.00303	0.00303	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CXCR2—periodontitis	0.00302	0.00302	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—VIP—periodontitis	0.00301	0.00301	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CCR2—periodontitis	0.00283	0.00283	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—ADRB1—periodontitis	0.00282	0.00282	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CXCR2—periodontitis	0.00274	0.00274	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—VIP—periodontitis	0.00273	0.00273	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00269	0.00269	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CXCR2—periodontitis	0.00268	0.00268	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CCR2—periodontitis	0.00257	0.00257	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00256	0.00256	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—ADRB1—periodontitis	0.00256	0.00256	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CXCL3—periodontitis	0.00252	0.00252	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—CCL2—periodontitis	0.00247	0.00247	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CXCR2—periodontitis	0.00244	0.00244	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00239	0.00239	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CCR2—periodontitis	0.00235	0.00235	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—ADRB1—periodontitis	0.00234	0.00234	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CXCL3—periodontitis	0.00223	0.00223	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VIP—periodontitis	0.00219	0.00219	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CCR2—periodontitis	0.00213	0.00213	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00213	0.00213	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—ADRB1—periodontitis	0.00212	0.00212	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CCR2—periodontitis	0.00209	0.00209	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—ADRB1—periodontitis	0.00208	0.00208	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CCL2—periodontitis	0.00205	0.00205	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CXCR2—periodontitis	0.00195	0.00195	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—CXCL8—periodontitis	0.00195	0.00195	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MMP3—periodontitis	0.00195	0.00195	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00194	0.00194	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCR2—periodontitis	0.0019	0.0019	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00189	0.00189	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—ADRB1—periodontitis	0.00189	0.00189	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CCL2—periodontitis	0.00182	0.00182	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VIP—periodontitis	0.00182	0.00182	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CXCR2—periodontitis	0.00162	0.00162	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CXCL8—periodontitis	0.00162	0.00162	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MMP3—periodontitis	0.00162	0.00162	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VIP—periodontitis	0.00162	0.00162	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00161	0.00161	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCR2—periodontitis	0.00152	0.00152	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADRB1—periodontitis	0.00151	0.00151	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CXCR2—periodontitis	0.00144	0.00144	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CXCL8—periodontitis	0.00144	0.00144	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MMP3—periodontitis	0.00144	0.00144	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00143	0.00143	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CCL2—periodontitis	0.00127	0.00127	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCR2—periodontitis	0.00126	0.00126	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADRB1—periodontitis	0.00126	0.00126	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NTRK1—periodontitis	0.00124	0.00124	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MMP3—periodontitis	0.00115	0.00115	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCR2—periodontitis	0.00112	0.00112	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADRB1—periodontitis	0.00111	0.00111	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CXCL8—periodontitis	0.0011	0.0011	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CCL2—periodontitis	0.00105	0.00105	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NTRK1—periodontitis	0.00103	0.00103	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CXCL8—periodontitis	0.001	0.001	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MMP3—periodontitis	0.000955	0.000955	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCL2—periodontitis	0.000934	0.000934	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CXCL8—periodontitis	0.000916	0.000916	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NTRK1—periodontitis	0.000913	0.000913	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MMP3—periodontitis	0.000849	0.000849	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CXCL8—periodontitis	0.000831	0.000831	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CXCL8—periodontitis	0.000813	0.000813	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCL2—periodontitis	0.000748	0.000748	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CXCL8—periodontitis	0.000739	0.000739	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FGF2—periodontitis	0.000676	0.000676	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL2—periodontitis	0.000621	0.000621	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CXCL8—periodontitis	0.000592	0.000592	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—periodontitis	0.000563	0.000563	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGF2—periodontitis	0.000561	0.000561	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL2—periodontitis	0.000552	0.000552	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MMP9—periodontitis	0.000535	0.000535	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGF2—periodontitis	0.000499	0.000499	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CXCL8—periodontitis	0.000491	0.000491	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—periodontitis	0.000467	0.000467	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MMP9—periodontitis	0.000444	0.000444	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TGFB1—periodontitis	0.000441	0.000441	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CXCL8—periodontitis	0.000436	0.000436	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—periodontitis	0.000415	0.000415	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MMP9—periodontitis	0.000395	0.000395	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TGFB1—periodontitis	0.000366	0.000366	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—periodontitis	0.000332	0.000332	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TGFB1—periodontitis	0.000325	0.000325	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—periodontitis	0.000276	0.000276	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—periodontitis	0.000245	0.000245	CbGpPWpGaD
